Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Investing in your 20s can set the foundation for a secure retirement. Discover the best options to maximize your growth.
17,680 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Public disclosures show surprising activity in major names, but smart investing hinges on fundamentals, risk, and a d...
A bold stake move in Hut 8 has sparked a new conversation about concentration, risk, and opportunity in crypto-relate...
Rising mortgage rates are reshaping how first-time buyers approach new homes. This article explains Meritage Homes’ f...
A shifting geopolitical landscape intersects AI, policy, and crypto. This article breaks down what Anthropic's used I...
A large fund trimmed its DigitalBridge position, sparking questions about stake moves, stock momentum, and how invest...
The battle between FedEx and UPS isn't just about packages—it's about dollars, margins, and future growth. This artic...
For the next 10 years, dividend stocks hold next potential with steady income and growth. Discover four dependable na...
JetBlue Airways sparked a rally as reports surfaced about a strategic review, including a possible sale. Here’s what ...
Telos (TLS) 2026 earnings outlook is shaping up as multiple revenue streams converge—from on-chain activity fees to s...
Upstart has been navigating a challenging stretch as the stock declines. This article breaks down whether the drop cr...
A new Firefox redesign adds an AI toggle that can turn off AI features with a click. For crypto enthusiasts and priva...